share_log

Argus Research Upgrades Allscripts Healthcare to Buy, Announces $26 Price Target

Benzinga Real-time News ·  Dec 7, 2022 14:44

Argus Research analyst Jasper Hellweg upgrades Allscripts Healthcare (NASDAQ:MDRX) from Hold to Buy and announces $26 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment